University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Steven R. Cummings, MD, FACP

Steven R. Cummings, MD, FACP

Professor Emeritus, Department of Medicine (General Internal Medicine), UCSF

Cancer Center Program Memberships

Affiliate Member

Education

Stanford University, Stanford, CA, B.A., 1969, Psychology
Union Theological Seminary, N.Y., N.Y., (no degree), 1970, Ethics
University of California San Francisco, M.D., 1976, Medicine


Professional Experience

  • 1976-1977
    Internship: San Francisco General Hospital (Internal Medicine)
  • 1977-1979
    Residency: University of California San Francisco, (Internal Medicine)
  • 1980-1982
    Fellowship: University of California San Francisco (Epidemiology and Preventive Medicine)
  • 1989-98
    Professor and Chief, Division of General Internal Medicine, UCSF
  • 1998
    Associate Chair for Clinical Research, Department of Medicine, UCSF; Professor of Medicine, Epidemiology & Biostatistics; Director of Coordinating Center
  • 1999
    Assistant Dean for Clinical Research

Honors & Awards

  • 1985-1990
    Henry J. Kaiser Faculty Fellowship Award in General Internal Medicine
  • 1988-present
    Board of Directors, National Osteoporosis Foundation
  • 1990-1994
    Advisory Panel on Osteoporosis, US Congress, Office of Technology Assessment
  • 1990-present
    Elected Faculty AOA
  • 1991-present
    Member, Scientific Advisory Board, National Osteoporosis Foundation
  • 1992-1993
    Consultant, World Health Organization (assigned to China)
  • 1995-present
    National Osteoporosis Foundation Clinical Guidelines Core Committee
  • 1996-present
    Elected, American Association of Physicians (AAP)
  • 1996-present
    Elected, Council of American Society for Bone & Mineral Research (ASBMR)

Selected Publications

  1. Cosman F, Peterson LR, Towler DA, Mitlak B, Wang Y, Cummings SR. Cardiovascular Safety of Abaloparatide in Postmenopausal Women with Osteoporosis: Analysis from the ACTIVE Phase 3 Trial. J Clin Endocrinol Metab. 2020 Jul 13.
    View on PubMed
  2. Vilaca T, Salam S, Schini M, Harnan S, Sutton A, Poku E, Allen IE, Cummings SR, Eastell R. Risks of Hip and Nonvertebral Fractures in Patients With CKD G3a-G5D: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2020 Jul 09.
    View on PubMed
  3. Cawthon PM, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, Magaziner JM, Newman AB, Brown T, Kiel DP, Cummings SR, Shardell M, Guralnik JM, Woodhouse LJ, Pahor M, Binder E, D'Agostino RB, Quian-Li X, Orwoll E, Landi F, Orwig D, Schaap L, Latham NK, Hirani V, Kwok T, Pereira SL, Rooks D, Kashiwa M, Torres-Gonzalez M, Menetski JP, Correa-De-Araujo R, Bhasin S. Establishing the Link Between Lean Mass and Grip Strength Cut Points With Mobility Disability and Other Health Outcomes: Proceedings of the Sarcopenia Definition and Outcomes Consortium Conference. J Gerontol A Biol Sci Med Sci. 2020 Jun 18; 75(7):1317-1323.
    View on PubMed
  4. Orwoll ES, Peters KE, Hellerstein M, Cummings SR, Evans WJ, Cawthon PM. The Importance of Muscle Versus Fat Mass in Sarcopenic Obesity: A Re-evaluation Using D3-Creatine Muscle Mass Versus DXA Lean Mass Measurements. J Gerontol A Biol Sci Med Sci. 2020 Jun 18; 75(7):1362-1368.
    View on PubMed
  5. Schafer MJ, Zhang X, Kumar A, Atkinson EJ, Zhu Y, Jachim S, Mazula DL, Brown AK, Berning M, Aversa Z, Kotajarvi B, Bruce CJ, Greason KL, Suri RM, Tracy RP, Cummings SR, White TA, LeBrasseur NK. The senescence-associated secretome as an indicator of age and medical risk. JCI Insight. 2020 Jun 18; 5(12).
    View on PubMed
  6. Vilaca T, Schini M, Harnan S, Sutton A, Poku E, Allen IE, Cummings SR, Eastell R. The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update. Bone. 2020 May 29; 137:115457.
    View on PubMed
  7. Cawthon PM, Blackwell T, Cummings SR, Orwoll ES, Duchowny KA, Kado DM, Stone KL, Ensrud KE, Cauley JA, Evans WJ. Muscle mass assessed by D3-Creatine dilution method and incident self-reported disability and mortality in a prospective observational study of community dwelling older men. J Gerontol A Biol Sci Med Sci. 2020 May 22.
    View on PubMed
  8. Cummings SR, Santora AC, Black DM, Russell RGG. History of alendronate. Bone. 2020 Aug; 137:115411.
    View on PubMed
  9. Cawthon PM, Parimi N, Langsetmo L, Cauley JA, Ensrud KE, Cummings SR, Lane NE, Hoffman AR, Lapidus J, Gill TM, McCulloch CE, Stefanick ML, Kado DM, Drieling R, Orwoll ES. Individual and joint trajectories of change in bone, lean mass and physical performance in older men. BMC Geriatr. 2020 May 05; 20(1):161.
    View on PubMed
  10. Zanker J, Patel S, Blackwell T, Duchowny K, Brennan-Olsen S, Cummings SR, Evans WJ, Orwoll ES, Scott D, Vogrin S, Cauley JA, Duque G, Cawthon PM. Walking Speed and Muscle Mass Estimated by the D3-Creatine Dilution Method Are Important Components of Sarcopenia Associated With Incident Mobility Disability in Older Men: A Classification and Regression Tree Analysis. J Am Med Dir Assoc. 2020 May 04.
    View on PubMed
  11. Reid IR, Green JR, Lyles KW, Reid DM, Trechsel U, Hosking DJ, Black DM, Cummings SR, Russell RGG, Eriksen EF. Zoledronate. Bone. 2020 Aug; 137:115390.
    View on PubMed
  12. Cawthon P, Orwoll E, Ensrud K, Cauley JA, Kritchevsky SB, Cummings SR, Newman A. Assessing the impact of the covid-19 pandemic and accompanying mitigation efforts on older adults. J Gerontol A Biol Sci Med Sci. 2020 Apr 20.
    View on PubMed
  13. Cummings SR, McCulloch C. Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab. Osteoporos Int. 2020 Jun; 31(6):1019-1021.
    View on PubMed
  14. Chotiyarnwong P, McCloskey E, Eastell R, McClung MR, Gielen E, Gostage J, McDermott M, Chines A, Huang S, Cummings SR. A Pooled Analysis of Fall Incidence From Placebo-Controlled Trials of Denosumab. J Bone Miner Res. 2020 Jun; 35(6):1014-1021.
    View on PubMed
  15. Kim KM, Lui LY, Cauley JA, Ensrud KE, Orwoll ES, Schousboe JT, Cummings SR. Red Cell Distribution Width Is a Risk Factor for Hip Fracture in Elderly Men Without Anemia. J Bone Miner Res. 2020 May; 35(5):869-874.
    View on PubMed
  16. Cummings SR, Eastell R. Stop (mis)classifying fractures as high- or low-trauma or as fragility fractures. Osteoporos Int. 2020 Jun; 31(6):1023-1024.
    View on PubMed
  17. Ferrari S, Eastell R, Napoli N, Schwartz A, Hofbauer LC, Chines A, Wang A, Pannacciulli N, Cummings SR. Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension. Bone. 2020 May; 134:115268.
    View on PubMed
  18. Newman AB, Kritchevsky SB, Guralnik JM, Cummings SR, Salive M, Kuchel GA, Schrack J, Morris MC, Weir D, Baccarelli A, Murabito JM, Ben-Shlomo Y, Espeland MA, Kirkland J, Melzer D, Ferrucci L. Accelerating the Search for Interventions Aimed at Expanding the Health Span in Humans: The Role of Epidemiology. J Gerontol A Biol Sci Med Sci. 2020 Jan 01; 75(1):77-86.
    View on PubMed
  19. de Las Fuentes L, Sung YJ, Sitlani CM, Avery CL, Bartz TM, Keyser C, Evans DS, Li X, Musani SK, Ruiter R, Smith AV, Sun F, Trompet S, Xu H, Arnett DK, Bis JC, Broeckel U, Busch EL, Chen YI, Correa A, Cummings SR, Floyd JS, Ford I, Guo X, Harris TB, Ikram MA, Lange L, Launer LJ, Reiner AP, Schwander K, Smith NL, Sotoodehnia N, Stewart JD, Stott DJ, Stürmer T, Taylor KD, Uitterlinden A, Vasan RS, Wiggins KL, Cupples LA, Gudnason V, Heckbert SR, Jukema JW, Liu Y, Psaty BM, Rao DC, Rotter JI, Stricker B, Wilson JG, Whitsel EA. Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestry. Pharmacogenomics J. 2020 Jun; 20(3):482-493.
    View on PubMed
  20. Schini M, Vilaca T, Poku E, Harnan S, Sutton A, Allen IE, Cummings SR, Eastell R. The risk of hip and non-vertebral fractures in patients with Parkinson's disease and parkinsonism: A systematic review and meta-analysis. Bone. 2020 Mar; 132:115173.
    View on PubMed

Go to UCSF Profiles, powered by CTSI